statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	662
RU - Federazione Russa	186
SG - Singapore	155
IT - Italia	71
CN - Cina	63
CI - Costa d'Avorio	60
BR - Brasile	57
IE - Irlanda	43
VN - Vietnam	29
DE - Germania	21
GB - Regno Unito	20
IN - India	17
SN - Senegal	16
FI - Finlandia	14
CA - Canada	13
FR - Francia	12
SE - Svezia	8
MX - Messico	7
UZ - Uzbekistan	7
ZA - Sudafrica	7
CZ - Repubblica Ceca	6
HK - Hong Kong	6
PL - Polonia	6
TR - Turchia	6
AR - Argentina	5
JP - Giappone	5
BE - Belgio	4
ES - Italia	4
NO - Norvegia	4
BD - Bangladesh	3
ID - Indonesia	3
IQ - Iraq	3
KR - Corea	3
PK - Pakistan	3
CH - Svizzera	2
DO - Repubblica Dominicana	2
EC - Ecuador	2
GR - Grecia	2
HU - Ungheria	2
IL - Israele	2
NL - Olanda	2
PE - Perù	2
AE - Emirati Arabi Uniti	1
AT - Austria	1
AU - Australia	1
CO - Colombia	1
CY - Cipro	1
HR - Croazia	1
JO - Giordania	1
LB - Libano	1
LT - Lituania	1
LU - Lussemburgo	1
MA - Marocco	1
MY - Malesia	1
NG - Nigeria	1
NP - Nepal	1
RO - Romania	1
SA - Arabia Saudita	1
SK - Slovacchia (Repubblica Slovacca)	1
TN - Tunisia	1
UA - Ucraina	1
Totale	1.564

Nome	#
A novel system for semiautomatic sample processing in chronic myeloid leukaemia: Increasing throughput without impacting on molecular monitoring at time of sars-cov-2 pandemic	181
ABL1-Directed Inhibitors for CML: Efficacy, Resistance and Future Perspectives	161
Efficacy of Dasatinib in a Very Elderly CML Patient Expressing a Rare E13a3 Bcr-Abl1 Fusion Transcript: A Case Report	160
Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts	158
Colony-forming cell assay detecting the co-expression of JAK2 V617F and BCR-ABL1 in the same clone: A case report	156
B-ALL relapses after autologous stem cell transplantation associated with a shift from e1a2 to e14a2 BCR-ABL transcripts: A case report	154
Efficacy of Nilotinib in a CML Patient Expressing the Three-way Complex Variant Translocation t(2;9;22)	145
Optimal Response in a Patient With CML Expressing BCR-ABL1 E6A2 Fusion Transcript With Nilotinib Therapy: A Case Report	131
Opportunities and challenges of liquid biopsy in thyroid cancer	130
Prognostic and Therapeutic Roles of the Insulin Growth Factor System in Glioblastoma	113
Targeting BCL-2 as a therapeutic strategy for primary p210BCR-ABL1-positive B-ALL cells	108
Totale	1.597

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	1	0	0	0	0	0	0	0	0	0	0	0	1
2021/2022	78	0	13	5	1	19	2	11	3	2	0	2	20
2022/2023	233	12	23	7	33	11	37	0	49	44	3	10	4
2023/2024	119	6	21	1	1	4	40	0	9	0	7	23	7
2024/2025	354	8	62	16	33	62	49	35	10	9	17	41	12
2025/2026	747	37	34	93	58	126	201	67	4	55	54	12	6
Totale													1.597